A Hundred Drugs Contend: Chinese Biopharma Gains US Foothold

Two China-Discovered Cancer Treatments May Win US FDA Approval This Year

 
• By Alaric DeArment
  
China USA or United States trade and American tariffs conflict with two opposing trading partners as an economic import and exports dispute concept with 3D illustration elements
While it's early days, Chinese drug makers are off to a strong start in gaining a foothold in the US market • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from China

More from Focus On Asia